Skip to content
Accessibility help

Search NICE…

Skip to content

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About

Search results

Skip to results

Type

TypeGuidance (153)News (8)

Status

StatusAwaiting development (24)Discontinued (26)In development (30)Published (67)

Last updated

Last updatedLast 3 months (6)Last 6 months (9)Last year (26)Last 3 years (52)

Guidance programme

Guidance programmeClinical guidelines (1)NICE guidelines (1)Technology appraisal guidance (152)

Showing 166 to 166 of 166 results for pembrolizumab

Sort by

Colorectal cancer patients with rare mutations to benefit from life-extending treatment
NICE recommends pembrolizumab for colorectal cancer patients with rare mutations.
Result type
News
Last updated
18 January 2024

Previous page
1
…
10
11
Current page 12
Page 12 of 12

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Knowledge resources

About NICE
Into practice
Get involved with NICE
Jobs
News
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2024. All rights reserved. Subject to Notice of rights.